-
1
-
-
84887155324
-
Cancer stem cell dynamics in tumor progression and metastasis: is the microenvironment to blame?
-
COI: 1:CAS:528:DC%2BC38XhslajsrnE, PID: 23089245
-
Fessler, E., Dijkgraaf, F. E., De Sousa, E., Melo, F., & Medema, J. P. (2013). Cancer stem cell dynamics in tumor progression and metastasis: is the microenvironment to blame? Cancer Letters, 341(1), 97–104.
-
(2013)
Cancer Letters
, vol.341
, Issue.1
, pp. 97-104
-
-
Fessler, E.1
Dijkgraaf, F.E.2
De Sousa, E.3
Melo, F.4
Medema, J.P.5
-
2
-
-
84901853867
-
Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance
-
COI: 1:CAS:528:DC%2BC2cXpslCrtrg%3D, PID: 24905005
-
Easwaran, H., Tsai, H. C., & Baylin, S. B. (2014). Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance. Molecular Cell, 54(5), 716–27.
-
(2014)
Molecular Cell
, vol.54
, Issue.5
, pp. 716-727
-
-
Easwaran, H.1
Tsai, H.C.2
Baylin, S.B.3
-
3
-
-
33750313208
-
Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells
-
COI: 1:CAS:528:DC%2BD28XhtVamsr3I, PID: 16990346
-
Clarke, M. F., Dick, J. E., Dirks, P. B., Eaves, C. J., Jamieson, C. H., Jones, D. L., et al. (2006). Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Research, 66(19), 9339–44.
-
(2006)
Cancer Research
, vol.66
, Issue.19
, pp. 9339-9344
-
-
Clarke, M.F.1
Dick, J.E.2
Dirks, P.B.3
Eaves, C.J.4
Jamieson, C.H.5
Jones, D.L.6
-
4
-
-
0037388204
-
Prospective identification of tumorigenic breast cancer cells
-
COI: 1:CAS:528:DC%2BD3sXivFSqtbs%3D, PID: 12629218
-
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003). Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America, 100(7), 3983–8.
-
(2003)
Proceedings of the National Academy of Sciences of the United States of America
, vol.100
, Issue.7
, pp. 3983-3988
-
-
Al-Hajj, M.1
Wicha, M.S.2
Benito-Hernandez, A.3
Morrison, S.J.4
Clarke, M.F.5
-
5
-
-
33846095137
-
Identification and expansion of human colon-cancer-initiating cells
-
COI: 1:CAS:528:DC%2BD2sXhsFOmug%3D%3D, PID: 17122771
-
Ricci-Vitiani, L., Lombardi, D. G., Pilozzi, E., Biffoni, M., Todaro, M., Peschle, C., & De Maria, R. (2007). Identification and expansion of human colon-cancer-initiating cells. Nature, 445(7123), 111–5.
-
(2007)
Nature
, vol.445
, Issue.7123
, pp. 111-115
-
-
Ricci-Vitiani, L.1
Lombardi, D.G.2
Pilozzi, E.3
Biffoni, M.4
Todaro, M.5
Peschle, C.6
De Maria, R.7
-
6
-
-
79251565207
-
Determination of somatic and cancer stem cell self-renewing symmetric division rate using sphere assays
-
COI: 1:CAS:528:DC%2BC3MXosVOgtw%3D%3D, PID: 21246056
-
Deleyrolle, L. P., Ericksson, G., Morrison, B. J., Lopez, J. A., Burrage, K., Burrage, P., et al. (2011). Determination of somatic and cancer stem cell self-renewing symmetric division rate using sphere assays. PloS One, 6(1), e15844.
-
(2011)
PloS One
, vol.6
, Issue.1
-
-
Deleyrolle, L.P.1
Ericksson, G.2
Morrison, B.J.3
Lopez, J.A.4
Burrage, K.5
Burrage, P.6
-
7
-
-
84956579802
-
Therapeutic strategies targeting cancer stem cells
-
COI: 1:CAS:528:DC%2BC2MXhs1ykt7bM, PID: 26362755
-
Yoshida, G. J., & Saya, H. (2016). Therapeutic strategies targeting cancer stem cells. Cancer Science, 107(1), 5–11.
-
(2016)
Cancer Science
, vol.107
, Issue.1
, pp. 5-11
-
-
Yoshida, G.J.1
Saya, H.2
-
8
-
-
62549108159
-
ABC transporters, drug resistance, and cancer stem cells
-
PID: 19224345
-
Dean, M. (2009). ABC transporters, drug resistance, and cancer stem cells. Journal of Mammary Gland Biology and Neoplasia, 14(1), 3–9.
-
(2009)
Journal of Mammary Gland Biology and Neoplasia
, vol.14
, Issue.1
, pp. 3-9
-
-
Dean, M.1
-
9
-
-
69249087671
-
Environment-mediated drug resistance: a major contributor to minimal residual disease
-
COI: 1:CAS:528:DC%2BD1MXhtVWhsb%2FP, PID: 19693095
-
Meads, M. B., Gatenby, R. A., & Dalton, W. S. (2009). Environment-mediated drug resistance: a major contributor to minimal residual disease. Nature Reviews Cancer, 9(9), 665–74.
-
(2009)
Nature Reviews Cancer
, vol.9
, Issue.9
, pp. 665-674
-
-
Meads, M.B.1
Gatenby, R.A.2
Dalton, W.S.3
-
10
-
-
84890860977
-
EpCAM expression in the prostate cancer makes the difference in the response to growth factors
-
COI: 1:CAS:528:DC%2BC3sXhvFOhu7%2FO, PID: 24309103
-
Yoshida, G. J., & Saya, H. (2014). EpCAM expression in the prostate cancer makes the difference in the response to growth factors. Biochemical and Biophysical Research Communications, 443(1), 239–45.
-
(2014)
Biochemical and Biophysical Research Communications
, vol.443
, Issue.1
, pp. 239-245
-
-
Yoshida, G.J.1
Saya, H.2
-
11
-
-
84936991599
-
TPO-induced metabolic reprogramming drives liver metastasis of colorectal cancer CD110+ tumor-initiating cells
-
COI: 1:CAS:528:DC%2BC2MXhtV2itb7J, PID: 26140605
-
Wu, Z., Wei, D., Gao, W., Xu, Y., Hu, Z., Ma, Z., et al. (2015). TPO-induced metabolic reprogramming drives liver metastasis of colorectal cancer CD110+ tumor-initiating cells. Cell Stem Cell, 17(1), 47–59.
-
(2015)
Cell Stem Cell
, vol.17
, Issue.1
, pp. 47-59
-
-
Wu, Z.1
Wei, D.2
Gao, W.3
Xu, Y.4
Hu, Z.5
Ma, Z.6
-
12
-
-
84921860188
-
Metabolic reprogramming orchestrates cancer stem cell properties in nasopharyngeal carcinoma
-
PID: 25483072
-
Shen, Y. A., Wang, C. Y., Hsieh, Y. T., Chen, Y. J., & Wei, Y. H. (2015). Metabolic reprogramming orchestrates cancer stem cell properties in nasopharyngeal carcinoma. Cell Cycle, 14(1), 86–98.
-
(2015)
Cell Cycle
, vol.14
, Issue.1
, pp. 86-98
-
-
Shen, Y.A.1
Wang, C.Y.2
Hsieh, Y.T.3
Chen, Y.J.4
Wei, Y.H.5
-
13
-
-
84904335873
-
Integrated analysis identifies different metabolic signatures for tumor-initiating cells in a murine glioblastoma model
-
COI: 1:CAS:528:DC%2BC2cXht1SqtrzP, PID: 24860177
-
Saga, I., Shibao, S., Okubo, J., Osuka, S., Kobayashi, Y., Yamada, S., et al. (2014). Integrated analysis identifies different metabolic signatures for tumor-initiating cells in a murine glioblastoma model. Neuro-Oncology, 16(8), 1048–56.
-
(2014)
Neuro-Oncology
, vol.16
, Issue.8
, pp. 1048-1056
-
-
Saga, I.1
Shibao, S.2
Okubo, J.3
Osuka, S.4
Kobayashi, Y.5
Yamada, S.6
-
14
-
-
0028091194
-
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
-
COI: 1:STN:280:DyaK2c7ltVKrsg%3D%3D, PID: 7509044
-
Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., et al. (1994). A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature, 367(6464), 645–8.
-
(1994)
Nature
, vol.367
, Issue.6464
, pp. 645-648
-
-
Lapidot, T.1
Sirard, C.2
Vormoor, J.3
Murdoch, B.4
Hoang, T.5
Caceres-Cortes, J.6
-
15
-
-
0030789242
-
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell
-
COI: 1:CAS:528:DyaK2sXkt1GrtLY%3D, PID: 9212098
-
Bonnet, D., & Dick, J. E. (1997). Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Medicine, 3(7), 730–7.
-
(1997)
Nature Medicine
, vol.3
, Issue.7
, pp. 730-737
-
-
Bonnet, D.1
Dick, J.E.2
-
16
-
-
13944274492
-
Leukemic stem cells in childhood high-risk ALL/t(9;22) and t(4;11) are present in primitive lymphoid-restricted CD34 + CD19- cells
-
COI: 1:CAS:528:DC%2BD2MXhsFKqtL4%3D, PID: 15735032
-
Hotfilder, M., Röttgers, S., Rosemann, A., Schrauder, A., Schrappe, M., Pieters, R., et al. (2005). Leukemic stem cells in childhood high-risk ALL/t(9;22) and t(4;11) are present in primitive lymphoid-restricted CD34 + CD19- cells. Cancer Research, 65(4), 1442–9.
-
(2005)
Cancer Research
, vol.65
, Issue.4
, pp. 1442-1449
-
-
Hotfilder, M.1
Röttgers, S.2
Rosemann, A.3
Schrauder, A.4
Schrappe, M.5
Pieters, R.6
-
17
-
-
20944434753
-
Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia
-
COI: 1:CAS:528:DC%2BD2MXkslOksLY%3D, PID: 15908956
-
Castor, A., Nilsson, L., Astrand-Grundström, I., Buitenhuis, M., Ramirez, C., Anderson, K., et al. (2005). Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia. Nature Medicine, 11(6), 630–7.
-
(2005)
Nature Medicine
, vol.11
, Issue.6
, pp. 630-637
-
-
Castor, A.1
Nilsson, L.2
Astrand-Grundström, I.3
Buitenhuis, M.4
Ramirez, C.5
Anderson, K.6
-
18
-
-
45149133254
-
CD34 + CD38 + CD19+ as well as CD34 + CD38-CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL
-
COI: 1:CAS:528:DC%2BD1cXntVCjtbc%3D, PID: 18418410
-
Kong, Y., Yoshida, S., Saito, Y., Doi, T., Nagatoshi, Y., Fukata, M., et al. (2008). CD34 + CD38 + CD19+ as well as CD34 + CD38-CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL. Leukemia, 22(6), 1207–13.
-
(2008)
Leukemia
, vol.22
, Issue.6
, pp. 1207-1213
-
-
Kong, Y.1
Yoshida, S.2
Saito, Y.3
Doi, T.4
Nagatoshi, Y.5
Fukata, M.6
-
19
-
-
45849102392
-
In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties
-
PID: 18598943
-
le Viseur, C., Hotfilder, M., Bomken, S., Wilson, K., Röttgers, S., Schrauder, A., et al. (2008). In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties. Cancer Cell, 14(1), 47–58.
-
(2008)
Cancer Cell
, vol.14
, Issue.1
, pp. 47-58
-
-
le Viseur, C.1
Hotfilder, M.2
Bomken, S.3
Wilson, K.4
Röttgers, S.5
Schrauder, A.6
-
20
-
-
77955512077
-
Understanding the cancer stem cell
-
COI: 1:CAS:528:DC%2BC3cXhtVSmtb7M, PID: 20664590
-
Bomken, S., Fiser, K., Heidenreich, O., & Vormoor, J. (2010). Understanding the cancer stem cell. British Journal of Cancer, 103(4), 439–45.
-
(2010)
British Journal of Cancer
, vol.103
, Issue.4
, pp. 439-445
-
-
Bomken, S.1
Fiser, K.2
Heidenreich, O.3
Vormoor, J.4
-
21
-
-
0141842674
-
Identification of a cancer stem cell in human brain tumors
-
COI: 1:CAS:528:DC%2BD3sXnvVSjtbc%3D, PID: 14522905
-
Singh, S. K., Clarke, I. D., Terasaki, M., Bonn, V. E., Hawkins, C., Squire, J., & Dirks, P. B. (2003). Identification of a cancer stem cell in human brain tumors. Cancer Research, 63(18), 5821–8.
-
(2003)
Cancer Research
, vol.63
, Issue.18
, pp. 5821-5828
-
-
Singh, S.K.1
Clarke, I.D.2
Terasaki, M.3
Bonn, V.E.4
Hawkins, C.5
Squire, J.6
Dirks, P.B.7
-
22
-
-
34250306257
-
Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells
-
COI: 1:CAS:528:DC%2BD2sXltl2gsL0%3D, PID: 17510412
-
Ho, M. M., Ng, A. V., Lam, S., & Hung, J. Y. (2007). Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Research, 67(10), 4827–33.
-
(2007)
Cancer Research
, vol.67
, Issue.10
, pp. 4827-4833
-
-
Ho, M.M.1
Ng, A.V.2
Lam, S.3
Hung, J.Y.4
-
23
-
-
33644825465
-
Stem-like cells in bone sarcomas: implications for tumorigenesis
-
Gibbs, C. P., Kukekov, V. G., Reith, J. D., Tchigrinova, O., Suslov, O. N., Scott, E. W., et al. (2007). Stem-like cells in bone sarcomas: implications for tumorigenesis. Neoplasia, 7(11), 967–76.
-
(2007)
Neoplasia
, vol.7
, Issue.11
, pp. 967-976
-
-
Gibbs, C.P.1
Kukekov, V.G.2
Reith, J.D.3
Tchigrinova, O.4
Suslov, O.N.5
Scott, E.W.6
-
24
-
-
84908193621
-
Impairment of lysosomal activity as a therapeutic modality targeting cancer stem cells of embryonal rhabdomyosarcoma cell line RD
-
Salerno, M., Avnet, S., Bonuccelli, G., Hosogi, S., Granchi, D., & Baldini, N. (2014). Impairment of lysosomal activity as a therapeutic modality targeting cancer stem cells of embryonal rhabdomyosarcoma cell line RD. PloS One, 9(10):e110340.
-
(2014)
PloS One
, vol.e110340
-
-
Salerno, M.1
Avnet, S.2
Bonuccelli, G.3
Hosogi, S.4
Granchi, D.5
Baldini, N.6
-
25
-
-
84879659043
-
Sphere-forming cell subsets with cancer stem cell properties in human musculoskeletal sarcomas
-
PID: 23636271
-
Salerno, M., Avnet, S., Bonuccelli, G., Eramo, A., De Maria, R., Gambarotti, M., et al. (2013). Sphere-forming cell subsets with cancer stem cell properties in human musculoskeletal sarcomas. International Journal of Oncology, 43(1), 95–102.
-
(2013)
International Journal of Oncology
, vol.43
, Issue.1
, pp. 95-102
-
-
Salerno, M.1
Avnet, S.2
Bonuccelli, G.3
Eramo, A.4
De Maria, R.5
Gambarotti, M.6
-
26
-
-
77952893906
-
CD133 expression in chemo-resistant Ewing sarcoma cells
-
COI: 1:CAS:528:DC%2BC3cXotlajsbg%3D
-
Jiang, X., Gwye, Y., Russell, D., Cao, C., Douglas, D., Hung, L., et al. (2010). CD133 expression in chemo-resistant Ewing sarcoma cells. BMC Cancer, 26(10), 116.
-
(2010)
BMC Cancer
, vol.26
, Issue.10
, pp. 116
-
-
Jiang, X.1
Gwye, Y.2
Russell, D.3
Cao, C.4
Douglas, D.5
Hung, L.6
-
27
-
-
53149105484
-
Cancer stem cell markers in common cancers - therapeutic implications
-
COI: 1:CAS:528:DC%2BD1cXhtFOltrjE, PID: 18775674
-
Klonisch, T., Wiechec, E., Hombach-Klonisch, S., Ande, S. R., Wesselborg, S., Schulze-Osthoff, K., & Los, M. (2008). Cancer stem cell markers in common cancers - therapeutic implications. Trends in Molecular Medicine, 14(10), 450–60.
-
(2008)
Trends in Molecular Medicine
, vol.14
, Issue.10
, pp. 450-460
-
-
Klonisch, T.1
Wiechec, E.2
Hombach-Klonisch, S.3
Ande, S.R.4
Wesselborg, S.5
Schulze-Osthoff, K.6
Los, M.7
-
28
-
-
23944445606
-
Neural stem cells and the origin of gliomas
-
COI: 1:CAS:528:DC%2BD2MXovVOru7g%3D, PID: 16120861
-
Sanai, N., Alvarez-Buylla, A., & Berger, M. S. (2005). Neural stem cells and the origin of gliomas. The New England Journal of Medicine, 353(8), 811–22.
-
(2005)
The New England Journal of Medicine
, vol.353
, Issue.8
, pp. 811-822
-
-
Sanai, N.1
Alvarez-Buylla, A.2
Berger, M.S.3
-
29
-
-
33846512398
-
Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma
-
COI: 1:CAS:528:DC%2BD2sXhtVSitLk%3D, PID: 17210912
-
Prince, M. E., Sivanandan, R., Kaczorowski, A., Wolf, G. T., Kaplan, M. J., Dalerba, P., et al. (2007). Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proceedings of the National Academy of Sciences of the United States of America, 104(3), 973–8.
-
(2007)
Proceedings of the National Academy of Sciences of the United States of America
, vol.104
, Issue.3
, pp. 973-978
-
-
Prince, M.E.1
Sivanandan, R.2
Kaczorowski, A.3
Wolf, G.T.4
Kaplan, M.J.5
Dalerba, P.6
-
30
-
-
28244472369
-
Prospective identification of tumorigenic prostate cancer stem cells
-
COI: 1:CAS:528:DC%2BD2MXht1KjsrzP, PID: 16322242
-
Collins, A. T., Berry, P. A., Hyde, C., Stower, M. J., & Maitland, N. J. (2005). Prospective identification of tumorigenic prostate cancer stem cells. Cancer Research, 65(23), 10946–51.
-
(2005)
Cancer Research
, vol.65
, Issue.23
, pp. 10946-10951
-
-
Collins, A.T.1
Berry, P.A.2
Hyde, C.3
Stower, M.J.4
Maitland, N.J.5
-
31
-
-
84857474200
-
CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors
-
COI: 1:CAS:528:DC%2BC38Xisl2rtLo%3D, PID: 21898409
-
Rocco, A., Liguori, E., Pirozzi, G., Tirino, V., Compare, D., Franco, R., et al. (2012). CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors. Journal of Cellular Physiology, 227(6), 2686–93.
-
(2012)
Journal of Cellular Physiology
, vol.227
, Issue.6
, pp. 2686-2693
-
-
Rocco, A.1
Liguori, E.2
Pirozzi, G.3
Tirino, V.4
Compare, D.5
Franco, R.6
-
32
-
-
33748967069
-
Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer
-
COI: 1:CAS:528:DC%2BD28Xht1yjs7vF, PID: 16824016
-
Nelson, C. M., & Bissell, M. J. (2006). Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. Annual Review of Cell and Developmental Biology, 22, 287–309.
-
(2006)
Annual Review of Cell and Developmental Biology
, vol.22
, pp. 287-309
-
-
Nelson, C.M.1
Bissell, M.J.2
-
33
-
-
73349134974
-
Hyaluronan-CD44 interactions in cancer: paradoxes and possibilities
-
COI: 1:CAS:528:DC%2BD1MXhsFGgur3L, PID: 20008845
-
Toole, B. P. (2009). Hyaluronan-CD44 interactions in cancer: paradoxes and possibilities. Clinical Cancer Research, 15(24), 7462–7468.
-
(2009)
Clinical Cancer Research
, vol.15
, Issue.24
, pp. 7462-7468
-
-
Toole, B.P.1
-
34
-
-
84884683059
-
Hyaluronan-based pericellular matrix: substrate electrostatic charges and early cell adhesion events
-
Fotia, C., Messina, G. M., Marletta, G., Baldini, N., & Ciapetti, G. (2013). Hyaluronan-based pericellular matrix: substrate electrostatic charges and early cell adhesion events. European Cells & Materials, 20(26), 133–49.
-
(2013)
European Cells & Materials
, vol.20
, Issue.26
, pp. 133-149
-
-
Fotia, C.1
Messina, G.M.2
Marletta, G.3
Baldini, N.4
Ciapetti, G.5
-
35
-
-
0035783042
-
Hyaluronan in morphogenesis
-
COI: 1:CAS:528:DC%2BD3MXis1SisLY%3D
-
Toole, B. P. (2001). Hyaluronan in morphogenesis. Seminars in Cell & Developmental Biology, 12(2), 79–87.
-
(2001)
Seminars in Cell & Developmental Biology
, vol.12
, Issue.2
, pp. 79-87
-
-
Toole, B.P.1
-
36
-
-
34249703990
-
The role of hyaluronic acid in hemopoietic stem cell biology
-
COI: 1:CAS:528:DC%2BD28Xosl2hurk%3D, PID: 17465836
-
Haylock, D. N., & Nilsson, S. K. (2006). The role of hyaluronic acid in hemopoietic stem cell biology. Regenerative Medicine, 1(4), 437–45.
-
(2006)
Regenerative Medicine
, vol.1
, Issue.4
, pp. 437-445
-
-
Haylock, D.N.1
Nilsson, S.K.2
-
37
-
-
79955004401
-
Hyaluronan and mesenchymal stem cells: from germ layer to cartilage and bone
-
Astachov, L., Vago, R., Aviv, M., & Nevo, Z. (2011). Hyaluronan and mesenchymal stem cells: from germ layer to cartilage and bone. Frontiers in Bioscience, 1(16), 261–76.
-
(2011)
Frontiers in Bioscience
, vol.1
, Issue.16
, pp. 261-276
-
-
Astachov, L.1
Vago, R.2
Aviv, M.3
Nevo, Z.4
-
38
-
-
84975123130
-
-
The glycocalyx and its significance in human medicine
-
Tarbell, J. M., & Cancel, L. M. (2016). The glycocalyx and its significance in human medicine. Journal of Internal Medicine. doi:.10.1111/joim.12465
-
(2016)
Journal of Internal Medicine
-
-
Tarbell, J.M.1
Cancel, L.M.2
-
39
-
-
0033667872
-
Hyaluronic acid as prognostic marker in resectable colorectal cancer
-
COI: 1:STN:280:DC%2BD3M%2FnvFeqsw%3D%3D, PID: 11122186
-
Llaneza, A., Vizoso, F., Rodríguez, J. C., Raigoso, P., García-Muñiz, J. L., Allende, M. T., & García-Morán, M. (2000). Hyaluronic acid as prognostic marker in resectable colorectal cancer. The British Journal of Surgery, 87(12), 1690–6.
-
(2000)
The British Journal of Surgery
, vol.87
, Issue.12
, pp. 1690-1696
-
-
Llaneza, A.1
Vizoso, F.2
Rodríguez, J.C.3
Raigoso, P.4
García-Muñiz, J.L.5
Allende, M.T.6
García-Morán, M.7
-
40
-
-
84959871794
-
Plasma hyaluronic acid level as a prognostic and monitoring marker of metastatic breast cancer
-
Peng, C., Wallwiener, M., Rudolph, A., Ćuk, K., Eilber, U., Celik, M., et al. (2015). Plasma hyaluronic acid level as a prognostic and monitoring marker of metastatic breast cancer. International Journal of Cancer, 138(10), 2499–509.
-
(2015)
International Journal of Cancer
, vol.138
, Issue.10
, pp. 2499-2509
-
-
Peng, C.1
Wallwiener, M.2
Rudolph, A.3
Ćuk, K.4
Eilber, U.5
Celik, M.6
-
41
-
-
0033970911
-
High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer
-
COI: 1:CAS:528:DC%2BD3cXnt1ansA%3D%3D, PID: 10646867
-
Anttila, M. A., Tammi, R. H., Tammi, M. I., Syrjänen, K. J., Saarikoski, S. V., & Kosma, V. M. (2000). High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer. Cancer Research, 60(1), 150–5.
-
(2000)
Cancer Research
, vol.60
, Issue.1
, pp. 150-155
-
-
Anttila, M.A.1
Tammi, R.H.2
Tammi, M.I.3
Syrjänen, K.J.4
Saarikoski, S.V.5
Kosma, V.M.6
-
42
-
-
37549017360
-
Hyaluronan synthases: a decade-plus of novel glycosyltransferases
-
COI: 1:CAS:528:DC%2BD2sXhsVamur%2FP, PID: 17981795
-
Weigel, P. H., & DeAngelis, P. L. (2007). Hyaluronan synthases: a decade-plus of novel glycosyltransferases. The Journal of Biological Chemistry, 282(51), 36777–81.
-
(2007)
The Journal of Biological Chemistry
, vol.282
, Issue.51
, pp. 36777-36781
-
-
Weigel, P.H.1
DeAngelis, P.L.2
-
43
-
-
0033230844
-
Expression of recombinant hyaluronan synthase (HAS) isoforms in CHO cells reduces cell migration and cell surface CD44
-
COI: 1:CAS:528:DyaK1MXms1ygsLk%3D, PID: 10527624
-
Brinck, J., & Heldin, P. (1999). Expression of recombinant hyaluronan synthase (HAS) isoforms in CHO cells reduces cell migration and cell surface CD44. Experimental Cell Research, 252(2), 342–51.
-
(1999)
Experimental Cell Research
, vol.252
, Issue.2
, pp. 342-351
-
-
Brinck, J.1
Heldin, P.2
-
44
-
-
0036262570
-
Hyaluronan promotes the malignant phenotype
-
COI: 1:CAS:528:DC%2BD38XjvFSjsb4%3D, PID: 11971857
-
Toole, B. P. (2002). Hyaluronan promotes the malignant phenotype. Glycobiology, 12(3), 37R–42R.
-
(2002)
Glycobiology
, vol.12
, Issue.3
, pp. 37-42
-
-
Toole, B.P.1
-
45
-
-
0022469459
-
Increased hyaluronate synthesis is required for fibroblast detachment and mitosis
-
COI: 1:CAS:528:DyaL28XlvVynsbc%3D, PID: 3101667
-
Brecht, M., Mayer, U., Schlosser, E., & Prehm, P. (1986). Increased hyaluronate synthesis is required for fibroblast detachment and mitosis. The Biochemical Journal, 239(2), 445–50.
-
(1986)
The Biochemical Journal
, vol.239
, Issue.2
, pp. 445-450
-
-
Brecht, M.1
Mayer, U.2
Schlosser, E.3
Prehm, P.4
-
46
-
-
84880059674
-
Cancer stem-like cell marker CD44 promotes bone metastases by enhancing tumorigenicity, cell motility, and hyaluronan production
-
COI: 1:CAS:528:DC%2BC3sXhtValu7%2FE, PID: 23633482
-
Hiraga, T., Ito, S., & Nakamura, H. (2013). Cancer stem-like cell marker CD44 promotes bone metastases by enhancing tumorigenicity, cell motility, and hyaluronan production. Cancer Research, 73(13), 4112–22.
-
(2013)
Cancer Research
, vol.73
, Issue.13
, pp. 4112-4122
-
-
Hiraga, T.1
Ito, S.2
Nakamura, H.3
-
47
-
-
85013218818
-
Hyaluronan synthase 2 overexpression is correlated with the tumorigenesis and metastasis of human breast cancer
-
PID: 26722395
-
Li, P., Xiang, T., Li, H., Li, Q., Yang, B., Huang, J., et al. (2015). Hyaluronan synthase 2 overexpression is correlated with the tumorigenesis and metastasis of human breast cancer. International Journal of Clinical and Experimental Pathology, 8(10), 12101–14.
-
(2015)
International Journal of Clinical and Experimental Pathology
, vol.8
, Issue.10
, pp. 12101-12114
-
-
Li, P.1
Xiang, T.2
Li, H.3
Li, Q.4
Yang, B.5
Huang, J.6
-
48
-
-
84893666005
-
Hyaluronan synthases (HAS1-3) in stromal and malignant cells correlate with breast cancer grade and predict patient survival
-
COI: 1:CAS:528:DC%2BC3sXhvFKgsLnP, PID: 24337597
-
Auvinen, P., Rilla, K., Tumelius, R., Tammi, M., Sironen, R., Soini, Y., et al. (2014). Hyaluronan synthases (HAS1-3) in stromal and malignant cells correlate with breast cancer grade and predict patient survival. Breast Cancer Research and Treatment, 143(2), 277–86.
-
(2014)
Breast Cancer Research and Treatment
, vol.143
, Issue.2
, pp. 277-286
-
-
Auvinen, P.1
Rilla, K.2
Tumelius, R.3
Tammi, M.4
Sironen, R.5
Soini, Y.6
-
49
-
-
25844473391
-
The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer
-
COI: 1:CAS:528:DC%2BD2MXhtVKisLfM, PID: 16125700
-
Udabage, L., Brownlee, G. R., Nilsson, S. K., & Brown, T. J. (2005). The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer. Experimental Cell Research, 310(1), 205–17.
-
(2005)
Experimental Cell Research
, vol.310
, Issue.1
, pp. 205-217
-
-
Udabage, L.1
Brownlee, G.R.2
Nilsson, S.K.3
Brown, T.J.4
-
50
-
-
0033609860
-
Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties
-
COI: 1:CAS:528:DyaK1MXls1ymur8%3D, PID: 10455188
-
Itano, N., Sawai, T., Yoshida, M., Lenas, P., Yamada, Y., Imagawa, M., et al. (1999). Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. The Journal of Biological Chemistry, 274(35), 25085–92.
-
(1999)
The Journal of Biological Chemistry
, vol.274
, Issue.35
, pp. 25085-25092
-
-
Itano, N.1
Sawai, T.2
Yoshida, M.3
Lenas, P.4
Yamada, Y.5
Imagawa, M.6
-
51
-
-
0033106004
-
Overproduction of hyaluronan by expression of the hyaluronan synthase Has2 enhances anchorage-independent growth and tumorigenicity
-
Kosaki, R., Watanabe, K., & Yamaguchi, Y. (1999). Overproduction of hyaluronan by expression of the hyaluronan synthase Has2 enhances anchorage-independent growth and tumorigenicity. Cancer Research, 59(5), 141–5.
-
(1999)
Cancer Research
, vol.59
, Issue.5
, pp. 141-145
-
-
Kosaki, R.1
Watanabe, K.2
Yamaguchi, Y.3
-
52
-
-
0035393499
-
Hyaluronan synthase 3 overexpression promotes the growth of TSU prostate cancer cells
-
COI: 1:CAS:528:DC%2BD3MXltVCjsrY%3D, PID: 11431361
-
Liu, N., Gao, F., Han, Z., Xu, X., Underhill, C. B., & Zhang, L. (2001). Hyaluronan synthase 3 overexpression promotes the growth of TSU prostate cancer cells. Cancer Research, 61(13), 5207–14.
-
(2001)
Cancer Research
, vol.61
, Issue.13
, pp. 5207-5214
-
-
Liu, N.1
Gao, F.2
Han, Z.3
Xu, X.4
Underhill, C.B.5
Zhang, L.6
-
53
-
-
84931407643
-
A novel role of low molecular weight hyaluronan in breast cancer metastasis
-
COI: 1:CAS:528:DC%2BC2MXmsFaiu7w%3D, PID: 25550464
-
Wu, M., Cao, M., He, Y., Liu, Y., Yang, C., Du, Y., et al. (2015). A novel role of low molecular weight hyaluronan in breast cancer metastasis. The FASEB Journal, 29(4), 1290–8.
-
(2015)
The FASEB Journal
, vol.29
, Issue.4
, pp. 1290-1298
-
-
Wu, M.1
Cao, M.2
He, Y.3
Liu, Y.4
Yang, C.5
Du, Y.6
-
54
-
-
84905283210
-
Accumulation of small hyaluronan oligosaccharides in tumour interstitial fluid correlates with lymphatic invasion and lymph node metastasis
-
COI: 1:CAS:528:DC%2BC2cXhtVagsbbE, PID: 24937668
-
Schmaus, A., Klusmeier, S., Rothley, M., Dimmler, A., Sipos, B., Faller, G., et al. (2014). Accumulation of small hyaluronan oligosaccharides in tumour interstitial fluid correlates with lymphatic invasion and lymph node metastasis. British Journal of Cancer, 111(3), 559–67.
-
(2014)
British Journal of Cancer
, vol.111
, Issue.3
, pp. 559-567
-
-
Schmaus, A.1
Klusmeier, S.2
Rothley, M.3
Dimmler, A.4
Sipos, B.5
Faller, G.6
-
55
-
-
84904860939
-
Emerging roles for hyaluronidase in cancer metastasis and therapy
-
PID: 25081524
-
McAtee, C. O., Barycki, J. J., & Simpson, M. A. (2014). Emerging roles for hyaluronidase in cancer metastasis and therapy. Advances in Cancer Research, 123, 1–34.
-
(2014)
Advances in Cancer Research
, vol.123
, pp. 1-34
-
-
McAtee, C.O.1
Barycki, J.J.2
Simpson, M.A.3
-
56
-
-
84958025863
-
Hyaluronan stimulates pancreatic cancer cell motility
-
Cheng, X. B., Kohi, S., Koga, A., Hirata, K., & Sato, N. (2015). Hyaluronan stimulates pancreatic cancer cell motility. Oncotarget, 7(4), 4829–40.
-
(2015)
Oncotarget
, vol.7
, Issue.4
, pp. 4829-4840
-
-
Cheng, X.B.1
Kohi, S.2
Koga, A.3
Hirata, K.4
Sato, N.5
-
57
-
-
2442597186
-
Selective expression and functional characteristics of three mammalian hyaluronan synthases in oncogenic malignant transformation
-
COI: 1:CAS:528:DC%2BD2cXjsVKms7k%3D, PID: 14724275
-
Itano, N., Sawai, T., Atsumi, F., Miyaishi, O., Taniguchi, S., Kannagi, R., et al. (2004). Selective expression and functional characteristics of three mammalian hyaluronan synthases in oncogenic malignant transformation. The Journal of Biological Chemistry, 279(18), 18679–87.
-
(2004)
The Journal of Biological Chemistry
, vol.279
, Issue.18
, pp. 18679-18687
-
-
Itano, N.1
Sawai, T.2
Atsumi, F.3
Miyaishi, O.4
Taniguchi, S.5
Kannagi, R.6
-
58
-
-
33745686460
-
Concurrent expression of hyaluronan biosynthetic and processing enzymes promotes growth and vascularization of prostate tumors in mice
-
COI: 1:CAS:528:DC%2BD28XnslSntb4%3D, PID: 16816377
-
Simpson, M. A. (2006). Concurrent expression of hyaluronan biosynthetic and processing enzymes promotes growth and vascularization of prostate tumors in mice. American Journal of Pathology, 169(1), 247–57.
-
(2006)
American Journal of Pathology
, vol.169
, Issue.1
, pp. 247-257
-
-
Simpson, M.A.1
-
59
-
-
84908254558
-
Role of receptor for hyaluronan-mediated motility (RHAMM) in human head and neck cancers
-
COI: 1:CAS:528:DC%2BC2cXlt1ChsLs%3D, PID: 24676428
-
Shigeishi, H., Higashikawa, K., & Takechi, M. (2014). Role of receptor for hyaluronan-mediated motility (RHAMM) in human head and neck cancers. Journal of Cancer Research and Clinical Oncology, 140(10), 1629–40.
-
(2014)
Journal of Cancer Research and Clinical Oncology
, vol.140
, Issue.10
, pp. 1629-1640
-
-
Shigeishi, H.1
Higashikawa, K.2
Takechi, M.3
-
60
-
-
84945476807
-
Expression of the hyaluronan-mediated motility receptor RHAMM in tumor budding cells identifies aggressive colorectal cancers
-
COI: 1:CAS:528:DC%2BC2MXhsVyrsLjJ, PID: 26351067
-
Koelzer, V. H., Huber, B., Mele, V., Iezzi, G., Trippel, M., Karamitopoulou, E., et al. (2015). Expression of the hyaluronan-mediated motility receptor RHAMM in tumor budding cells identifies aggressive colorectal cancers. Human Pathology, 46(11), 1573–81.
-
(2015)
Human Pathology
, vol.46
, Issue.11
, pp. 1573-1581
-
-
Koelzer, V.H.1
Huber, B.2
Mele, V.3
Iezzi, G.4
Trippel, M.5
Karamitopoulou, E.6
-
61
-
-
84944737336
-
Upregulation of hyaluronan-mediated motility receptor in hepatocellular carcinoma predicts poor survival
-
PID: 26788183
-
He, X., Liao, W., Li, Y., Wang, Y., Chen, Q., Jin, J., & He, S. (2015). Upregulation of hyaluronan-mediated motility receptor in hepatocellular carcinoma predicts poor survival. Oncology Letters, 10(6), 3639–3646.
-
(2015)
Oncology Letters
, vol.10
, Issue.6
, pp. 3639-3646
-
-
He, X.1
Liao, W.2
Li, Y.3
Wang, Y.4
Chen, Q.5
Jin, J.6
He, S.7
-
62
-
-
0034758718
-
Hyaluronate receptors mediating glioma cell migration and proliferation
-
COI: 1:STN:280:DC%2BD3MnmvFyrtA%3D%3D, PID: 11716065
-
Akiyama, Y., Jung, S., Salhia, B., Lee, S., Hubbard, S., Taylor, M., et al. (2001). Hyaluronate receptors mediating glioma cell migration and proliferation. Journal of Neuro-Oncology, 53(2), 115–27.
-
(2001)
Journal of Neuro-Oncology
, vol.53
, Issue.2
, pp. 115-127
-
-
Akiyama, Y.1
Jung, S.2
Salhia, B.3
Lee, S.4
Hubbard, S.5
Taylor, M.6
-
63
-
-
84969373529
-
Receptor for hyaluronic acid- mediated motility (RHAMM) regulates HT1080 fibrosarcoma cell proliferation via a β-catenin/c-myc signaling axis
-
COI: 1:CAS:528:DC%2BC28Xhs12gsr8%3D, PID: 26825774
-
Kouvidi, K., Berdiaki, A., Tzardi, M., Karousou, E., Passi, A., Nikitovic, D., & Tzanakakis, G. N. (2016). Receptor for hyaluronic acid- mediated motility (RHAMM) regulates HT1080 fibrosarcoma cell proliferation via a β-catenin/c-myc signaling axis. Biochimica et Biophysica Acta, 1860(4), 814–24.
-
(2016)
Biochimica et Biophysica Acta
, vol.1860
, Issue.4
, pp. 814-824
-
-
Kouvidi, K.1
Berdiaki, A.2
Tzardi, M.3
Karousou, E.4
Passi, A.5
Nikitovic, D.6
Tzanakakis, G.N.7
-
64
-
-
44749091840
-
Involvement of CD44, a molecule with a thousand faces, in cancer dissemination
-
COI: 1:CAS:528:DC%2BD1cXntlGhtrc%3D, PID: 18467123
-
Naor, D., Wallach-Dayan, S. B., Zahalka, M. A., & Sionov, R. V. (2008). Involvement of CD44, a molecule with a thousand faces, in cancer dissemination. Seminars in Cancer Biology, 18(4), 260–7.
-
(2008)
Seminars in Cancer Biology
, vol.18
, Issue.4
, pp. 260-267
-
-
Naor, D.1
Wallach-Dayan, S.B.2
Zahalka, M.A.3
Sionov, R.V.4
-
65
-
-
79953042645
-
CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?
-
PID: 21390059
-
Zöller, M. (2011). CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nature Reviews Cancer, 11(4), 254–67.
-
(2011)
Nature Reviews Cancer
, vol.11
, Issue.4
, pp. 254-267
-
-
Zöller, M.1
-
66
-
-
0037227965
-
CD44: from adhesion molecules to signalling regulators
-
COI: 1:CAS:528:DC%2BD3sXptV0%3D, PID: 12511867
-
Ponta, H., Sherman, L., & Herrlich, P. A. (2003). CD44: from adhesion molecules to signalling regulators. Nature Reviews Molecular Cell Biology, 4(1), 33–45.
-
(2003)
Nature Reviews Molecular Cell Biology
, vol.4
, Issue.1
, pp. 33-45
-
-
Ponta, H.1
Sherman, L.2
Herrlich, P.A.3
-
67
-
-
0020577072
-
A cell-surface molecule involved in organ-specific homing of lymphocytes
-
COI: 1:CAS:528:DyaL3sXksFWlsbY%3D, PID: 6866086
-
Gallatin, W. M., Weissman, I. L., & Butcher, E. C. (1983). A cell-surface molecule involved in organ-specific homing of lymphocytes. Nature, 304(5921), 30–4.
-
(1983)
Nature
, vol.304
, Issue.5921
, pp. 30-34
-
-
Gallatin, W.M.1
Weissman, I.L.2
Butcher, E.C.3
-
68
-
-
84940988452
-
Key roles of hyaluronan and its CD44 receptor in the stemness and survival of cancer stem cells
-
Chanmee, T., Ontong, P., Kimata, K., & Itano, N. (2015). Key roles of hyaluronan and its CD44 receptor in the stemness and survival of cancer stem cells. Frontiers in Oncology 5(180). doi:10.3389/fonc.2015.00180.
-
(2015)
Frontiers in Oncology
, vol.5
, Issue.180
-
-
Chanmee, T.1
Ontong, P.2
Kimata, K.3
Itano, N.4
-
69
-
-
0030789004
-
CD44 is involved in tumor angiogenesis; an activation antigen on human endothelial cells
-
COI: 1:CAS:528:DyaK2sXkvVWmsro%3D, PID: 9242547
-
Griffioen, A. W., Coenen, M. J., Damen, C. A., Hellwig, S. M., van Weering, D. H., Vooys, W., et al. (1997). CD44 is involved in tumor angiogenesis; an activation antigen on human endothelial cells. Blood, 90(3), 1150–9.
-
(1997)
Blood
, vol.90
, Issue.3
, pp. 1150-1159
-
-
Griffioen, A.W.1
Coenen, M.J.2
Damen, C.A.3
Hellwig, S.M.4
van Weering, D.H.5
Vooys, W.6
-
70
-
-
3042697038
-
Hyaluronan: from extracellular glue to pericellular cue
-
COI: 1:CAS:528:DC%2BD2cXlt1OktrY%3D, PID: 15229478
-
Toole, B. P. (2004). Hyaluronan: from extracellular glue to pericellular cue. Nature Reviews Cancer, 4(7), 528–39.
-
(2004)
Nature Reviews Cancer
, vol.4
, Issue.7
, pp. 528-539
-
-
Toole, B.P.1
-
71
-
-
34247119777
-
The magic glue hyaluronan and its eraser hyaluronidase: a biological overview
-
COI: 1:CAS:528:DC%2BD2sXksFahsLc%3D, PID: 17408700
-
Girish, K. S., & Kemparaju, K. (2007). The magic glue hyaluronan and its eraser hyaluronidase: a biological overview. Life Sciences, 80(21), 1921–43.
-
(2007)
Life Sciences
, vol.80
, Issue.21
, pp. 1921-1943
-
-
Girish, K.S.1
Kemparaju, K.2
-
72
-
-
33646536589
-
The emerging role of CD44 in regulating skeletal micrometastasis
-
COI: 1:CAS:528:DC%2BD28XkvVymsrk%3D, PID: 15979783
-
Hill, A., McFarlane, S., Johnston, P. G., & Waugh, D. J. (2006). The emerging role of CD44 in regulating skeletal micrometastasis. Cancer Letters, 237(1), 1–9.
-
(2006)
Cancer Letters
, vol.237
, Issue.1
, pp. 1-9
-
-
Hill, A.1
McFarlane, S.2
Johnston, P.G.3
Waugh, D.J.4
-
73
-
-
73349088160
-
Regulation of stemness and stem cell niche of mesenchymal stem cells: implications in tumorigenesis and metastasis
-
COI: 1:CAS:528:DC%2BD1MXhsFSgsr3L, PID: 19847802
-
Kuhn, N. Z., & Tuan, R. S. (2010). Regulation of stemness and stem cell niche of mesenchymal stem cells: implications in tumorigenesis and metastasis. Journal of Cellular Physiology, 222(2), 268–77.
-
(2010)
Journal of Cellular Physiology
, vol.222
, Issue.2
, pp. 268-277
-
-
Kuhn, N.Z.1
Tuan, R.S.2
-
74
-
-
0032080068
-
The hyaluronan receptor RHAMM regulates extracellular-regulated kinase
-
COI: 1:CAS:528:DyaK1cXjtFGrsrk%3D, PID: 9556628
-
Zhang, S., Chang, M. C., Zylka, D., Turley, S., Harrison, R., & Turley, E. A. (1998). The hyaluronan receptor RHAMM regulates extracellular-regulated kinase. The Journal of Biological Chemistry, 273(18), 11342–8.
-
(1998)
The Journal of Biological Chemistry
, vol.273
, Issue.18
, pp. 11342-11348
-
-
Zhang, S.1
Chang, M.C.2
Zylka, D.3
Turley, S.4
Harrison, R.5
Turley, E.A.6
-
75
-
-
0037085254
-
Signaling properties of hyaluronan receptors
-
COI: 1:CAS:528:DC%2BD38XhsFeqsbo%3D, PID: 11717317
-
Turley, E. A., Noble, P. W., & Bourguignon, L. Y. (2002). Signaling properties of hyaluronan receptors. The Journal of Biological Chemistry, 277(7), 4589–92.
-
(2002)
The Journal of Biological Chemistry
, vol.277
, Issue.7
, pp. 4589-4592
-
-
Turley, E.A.1
Noble, P.W.2
Bourguignon, L.Y.3
-
76
-
-
84965062883
-
RHAMM splice variants confer radiosensitivity in human breast cancer cell lines
-
Schütze, A., Vogeley, C., Gorges, T., Twarock, S., Butschan, J., Babayan, A., et al. (2016). RHAMM splice variants confer radiosensitivity in human breast cancer cell lines. Oncotarget. doi:10.18632/oncotarget.7258.
-
(2016)
Oncotarget
-
-
Schütze, A.1
Vogeley, C.2
Gorges, T.3
Twarock, S.4
Butschan, J.5
Babayan, A.6
-
77
-
-
3843096002
-
RHAMM expression and isoform balance predict aggressive disease and poor survival in multiple myeloma
-
COI: 1:CAS:528:DC%2BD2cXmslKgsb8%3D, PID: 15105292
-
Maxwell, C. A., Rasmussen, E., Zhan, F., Keats, J. J., Adamia, S., Strachan, E., et al. (2004). RHAMM expression and isoform balance predict aggressive disease and poor survival in multiple myeloma. Blood, 104(4), 1151–8.
-
(2004)
Blood
, vol.104
, Issue.4
, pp. 1151-1158
-
-
Maxwell, C.A.1
Rasmussen, E.2
Zhan, F.3
Keats, J.J.4
Adamia, S.5
Strachan, E.6
-
78
-
-
2342537511
-
CD44v6: a target for antibody-based cancer therapy
-
COI: 1:CAS:528:DC%2BD2cXksFSit7s%3D, PID: 14762695
-
Heider, K. H., Kuthan, H., Stehle, G., & Munzert, G. (2004). CD44v6: a target for antibody-based cancer therapy. Cancer Immunology, Immunotherapy, 53(7), 567–79.
-
(2004)
Cancer Immunology, Immunotherapy
, vol.53
, Issue.7
, pp. 567-579
-
-
Heider, K.H.1
Kuthan, H.2
Stehle, G.3
Munzert, G.4
-
79
-
-
84940054659
-
Concise review: emerging role of CD44 in cancer stem cells: a promising biomarker and therapeutic target
-
COI: 1:CAS:528:DC%2BC28Xlt12nsLY%3D, PID: 26136504
-
Yan, Y., Zuo, X., & Wei, D. (2015). Concise review: emerging role of CD44 in cancer stem cells: a promising biomarker and therapeutic target. Stem Cells Translational Medicine, 4(9), 1033–43.
-
(2015)
Stem Cells Translational Medicine
, vol.4
, Issue.9
, pp. 1033-1043
-
-
Yan, Y.1
Zuo, X.2
Wei, D.3
-
80
-
-
84955493784
-
Enrichment of CD44 in basal-type breast cancer correlates with EMT, cancer stem cell gene profile, and prognosis
-
Xu, H., Tian, Y., Yuan, X., Liu, Y., Wu, H., Liu, Q., et al. (2016). Enrichment of CD44 in basal-type breast cancer correlates with EMT, cancer stem cell gene profile, and prognosis. Onco Targets and Theraphy, 9, 431–44.
-
(2016)
Onco Targets and Theraphy
, vol.9
, pp. 431-444
-
-
Xu, H.1
Tian, Y.2
Yuan, X.3
Liu, Y.4
Wu, H.5
Liu, Q.6
-
81
-
-
84934277764
-
CD44, Hyaluronan, the hematopoietic stem cell, and leukemia-initiating cells
-
Zöller, M. (2015). CD44, Hyaluronan, the hematopoietic stem cell, and leukemia-initiating cells. Frontiers in Immunology 6(235). doi:10.3389/fimmu.2015.00235.
-
(2015)
Frontiers in Immunology
, vol.6
, Issue.235
-
-
Zöller, M.1
-
82
-
-
84935135038
-
Hyaluronan, inflammation, and breast cancer progression
-
Schwertfeger, K.L., Cowman, M.K., Telmer, P.G., Turley, E.A., & McCarthy, JB. (2015). Hyaluronan, inflammation, and breast cancer progression. Frontiers in Immunology 6(236). doi:10.3389/fimmu.2015.00236.
-
(2015)
Frontiers in Immunology
, vol.6
, Issue.236
-
-
Schwertfeger, K.L.1
Cowman, M.K.2
Telmer, P.G.3
Turley, E.A.4
McCarthy, J.B.5
-
83
-
-
84896115102
-
CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis
-
Todaro, M., Gaggianesi, M., Catalano, V., Benfante, A., Iovino, F., Biffoni, M., et al. (2014). CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis. Cell Stem Cell, 14(3), 42–56.
-
(2014)
Cell Stem Cell
, vol.14
, Issue.3
, pp. 42-56
-
-
Todaro, M.1
Gaggianesi, M.2
Catalano, V.3
Benfante, A.4
Iovino, F.5
Biffoni, M.6
-
84
-
-
84900000022
-
CD44v8-10 is a cancer-specific marker for gastric cancer stem cells
-
COI: 1:CAS:528:DC%2BC2cXnt1ars7g%3D, PID: 24618343
-
Lau, W. M., Teng, E., Chong, H. S., Lopez, K. A., Tay, A. Y., Salto-Tellez, M., et al. (2014). CD44v8-10 is a cancer-specific marker for gastric cancer stem cells. Cancer Research, 74(9), 2630–41.
-
(2014)
Cancer Research
, vol.74
, Issue.9
, pp. 2630-2641
-
-
Lau, W.M.1
Teng, E.2
Chong, H.S.3
Lopez, K.A.4
Tay, A.Y.5
Salto-Tellez, M.6
-
85
-
-
84866559462
-
Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma
-
COI: 1:CAS:528:DC%2BC38XhtlyqsrnE, PID: 22847005
-
Bourguignon, L. Y., Wong, G., Earle, C., & Chen, L. (2012). Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma. The Journal of Biological Chemistry, 287(39), 32800–24.
-
(2012)
The Journal of Biological Chemistry
, vol.287
, Issue.39
, pp. 32800-32824
-
-
Bourguignon, L.Y.1
Wong, G.2
Earle, C.3
Chen, L.4
-
86
-
-
61349189010
-
CD44 variant isoforms promote metastasis formation by a tumor cell-matrix cross-talk that supports adhesion and apoptosis resistance
-
COI: 1:CAS:528:DC%2BD1MXitlWgsLc%3D, PID: 19208744
-
Klingbeil, P., Marhaba, R., Jung, T., Kirmse, R., Ludwig, T., & Zöller, M. (2009). CD44 variant isoforms promote metastasis formation by a tumor cell-matrix cross-talk that supports adhesion and apoptosis resistance. Molecular Cancer Research, 7(2), 168–79.
-
(2009)
Molecular Cancer Research
, vol.7
, Issue.2
, pp. 168-179
-
-
Klingbeil, P.1
Marhaba, R.2
Jung, T.3
Kirmse, R.4
Ludwig, T.5
Zöller, M.6
-
87
-
-
70149123439
-
CD44v6 dependence of premetastatic niche preparation by exosomes
-
COI: 1:CAS:528:DC%2BD1MXhtFKrsb7K, PID: 19794968
-
Jung, T., Castellana, D., Klingbeil, P., Cuesta Hernández, I., Vitacolonna, M., Orlicky, D. J., et al. (2009). CD44v6 dependence of premetastatic niche preparation by exosomes. Neoplasia, 11(10), 1093–105.
-
(2009)
Neoplasia
, vol.11
, Issue.10
, pp. 1093-1105
-
-
Jung, T.1
Castellana, D.2
Klingbeil, P.3
Cuesta Hernández, I.4
Vitacolonna, M.5
Orlicky, D.J.6
-
88
-
-
84886791438
-
CD44 promotes Kras-dependent lung adenocarcinoma
-
COI: 1:CAS:528:DC%2BC38XhslKmt7%2FI, PID: 23208496
-
Zhao, P., Damerow, M. S., Stern, P., Liu, A. H., Sweet-Cordero, A., & Siziopikou, K. (2013). CD44 promotes Kras-dependent lung adenocarcinoma. Oncogene, 32(43), 5186–90.
-
(2013)
Oncogene
, vol.32
, Issue.43
, pp. 5186-5190
-
-
Zhao, P.1
Damerow, M.S.2
Stern, P.3
Liu, A.H.4
Sweet-Cordero, A.5
Siziopikou, K.6
-
89
-
-
0027499085
-
Expression of CD44R1 adhesion molecule in colon carcinomas and metastases
-
COI: 1:STN:280:DyaK3s7ps1entA%3D%3D, PID: 8095628
-
Tanabe, K. K., Ellis, L. M., & Saya, H. (1993). Expression of CD44R1 adhesion molecule in colon carcinomas and metastases. Lancet, 341(8847), 725–6.
-
(1993)
Lancet
, vol.341
, Issue.8847
, pp. 725-726
-
-
Tanabe, K.K.1
Ellis, L.M.2
Saya, H.3
-
90
-
-
84919846591
-
Brain metastasis is predetermined in early stages of cutaneous melanoma by CD44v6 expression through epigenetic regulation of the spliceosome
-
COI: 1:CAS:528:DC%2BC2cXitFOgtrvP
-
Marzese, D. M., Liu, M., Huynh, J. L., Hirose, H., Donovan, N. C., Huynh, K. T., et al. (2015). Brain metastasis is predetermined in early stages of cutaneous melanoma by CD44v6 expression through epigenetic regulation of the spliceosome. Pigment Cell & Melanoma Research, 28(1), 82–93.
-
(2015)
Pigment Cell & Melanoma Research
, vol.28
, Issue.1
, pp. 82-93
-
-
Marzese, D.M.1
Liu, M.2
Huynh, J.L.3
Hirose, H.4
Donovan, N.C.5
Huynh, K.T.6
-
91
-
-
84908448807
-
Evaluation of CD44 variant expression in oral, head and neck squamous cell carcinomas using a triple approach and its clinical significance
-
COI: 1:CAS:528:DC%2BC2cXitFSiur7K, PID: 25280025
-
Athanassiou-Papaefthymiou, M., Shkeir, O., Kim, D., Divi, V., Matossian, M., Owen, J. H., et al. (2014). Evaluation of CD44 variant expression in oral, head and neck squamous cell carcinomas using a triple approach and its clinical significance. International Journal of Immunopathology and Pharmacology, 27(3), 337–49.
-
(2014)
International Journal of Immunopathology and Pharmacology
, vol.27
, Issue.3
, pp. 337-349
-
-
Athanassiou-Papaefthymiou, M.1
Shkeir, O.2
Kim, D.3
Divi, V.4
Matossian, M.5
Owen, J.H.6
-
92
-
-
84945156824
-
CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer
-
COI: 1:CAS:528:DC%2BC2MXhsFajurnP, PID: 26250934
-
Tjhay, F., Motohara, T., Tayama, S., Narantuya, D., Fujimoto, K., Guo, J., et al. (2015). CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer. Cancer Science, 106(10), 1421–8.
-
(2015)
Cancer Science
, vol.106
, Issue.10
, pp. 1421-1428
-
-
Tjhay, F.1
Motohara, T.2
Tayama, S.3
Narantuya, D.4
Fujimoto, K.5
Guo, J.6
-
93
-
-
84946917241
-
Dual role of CD44 isoforms in ampullary adenocarcinoma: CD44s predicts poor prognosis in early cancer and CD44ν is an indicator for recurrence in advanced cancer
-
Wu, C.L., Chao, Y.J., Yang, T.M., Chen, Y.L., Chang, K.C., & Hsu, H.P., et al. (2015). Dual role of CD44 isoforms in ampullary adenocarcinoma: CD44s predicts poor prognosis in early cancer and CD44ν is an indicator for recurrence in advanced cancer. BMC Cancer 15(903). doi:10.1186/s12885-015-1924-3.
-
(2015)
BMC Cancer
, vol.15
, Issue.903
-
-
Wu, C.L.1
Chao, Y.J.2
Yang, T.M.3
Chen, Y.L.4
Chang, K.C.5
Hsu, H.P.6
-
94
-
-
55849117368
-
Generation of mouse induced pluripotent stem cells without viral vectors
-
COI: 1:CAS:528:DC%2BD1cXhtlaltLzO, PID: 18845712
-
Okita, K., Nakagawa, M., Hyenjong, H., Ichisaka, T., & Yamanaka, S. (2008). Generation of mouse induced pluripotent stem cells without viral vectors. Science, 322(5903), 949–53.
-
(2008)
Science
, vol.322
, Issue.5903
, pp. 949-953
-
-
Okita, K.1
Nakagawa, M.2
Hyenjong, H.3
Ichisaka, T.4
Yamanaka, S.5
-
95
-
-
84855781227
-
Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells
-
COI: 1:CAS:528:DC%2BC3MXnslSksbg%3D, PID: 21685938
-
Bourguignon, L. Y., Earle, C., Wong, G., Spevak, C. C., & Krueger, K. (2012). Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells. Oncogene, 31(2), 149–60.
-
(2012)
Oncogene
, vol.31
, Issue.2
, pp. 149-160
-
-
Bourguignon, L.Y.1
Earle, C.2
Wong, G.3
Spevak, C.C.4
Krueger, K.5
-
96
-
-
67650810301
-
Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the NANOG, OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs
-
COI: 1:CAS:528:DC%2BD1MXhtFWhtLfJ, PID: 19480567
-
Kashyap, V., Rezende, N. C., Scotland, K. B., Shaffer, S. M., Persson, J. L., Gudas, L. J., & Mongan, N. P. (2009). Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the NANOG, OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs. Stem Cells and Development, 18(7), 1093–108.
-
(2009)
Stem Cells and Development
, vol.18
, Issue.7
, pp. 1093-1108
-
-
Kashyap, V.1
Rezende, N.C.2
Scotland, K.B.3
Shaffer, S.M.4
Persson, J.L.5
Gudas, L.J.6
Mongan, N.P.7
-
97
-
-
47749116454
-
Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells
-
COI: 1:CAS:528:DC%2BD1cXntFSmsrw%3D, PID: 18441325
-
Bourguignon, L. Y., Peyrollier, K., Xia, W., & Gilad, E. (2008). Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells. The Journal of Biological Chemistry, 283(25), 17635–51.
-
(2008)
The Journal of Biological Chemistry
, vol.283
, Issue.25
, pp. 17635-17651
-
-
Bourguignon, L.Y.1
Peyrollier, K.2
Xia, W.3
Gilad, E.4
-
98
-
-
79952767543
-
Role of hyaluronan-mediated CD44 signaling in head and neck squamous cell carcinoma progression and chemoresistance
-
COI: 1:CAS:528:DC%2BC3MXktFans7w%3D, PID: 21356346
-
Wang, S. J., & Bourguignon, L. Y. (2011). Role of hyaluronan-mediated CD44 signaling in head and neck squamous cell carcinoma progression and chemoresistance. American Journal of Pathology, 178(3), 956–63.
-
(2011)
American Journal of Pathology
, vol.178
, Issue.3
, pp. 956-963
-
-
Wang, S.J.1
Bourguignon, L.Y.2
-
99
-
-
70350362953
-
Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the Production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells
-
COI: 1:CAS:528:DC%2BD1MXhtFCgs7rO, PID: 19633292
-
Bourguignon, L. Y., Spevak, C. C., Wong, G., Xia, W., & Gilad, E. (2009). Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the Production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells. The Journal of Biological Chemistry, 284(39), 26533–46.
-
(2009)
The Journal of Biological Chemistry
, vol.284
, Issue.39
, pp. 26533-26546
-
-
Bourguignon, L.Y.1
Spevak, C.C.2
Wong, G.3
Xia, W.4
Gilad, E.5
-
100
-
-
84886243809
-
Maintenance of stem cell self-renewal in head and neck cancers requires actions of GSK3β influenced by CD44 and RHAMM
-
COI: 1:CAS:528:DC%2BC3sXhvVCjs7fJ, PID: 23649588
-
Shigeishi, H., Biddle, A., Gammon, L., Emich, H., Rodini, C. O., Gemenetzidis, E., et al. (2013). Maintenance of stem cell self-renewal in head and neck cancers requires actions of GSK3β influenced by CD44 and RHAMM. Stem Cells, 31(10), 2073–83.
-
(2013)
Stem Cells
, vol.31
, Issue.10
, pp. 2073-2083
-
-
Shigeishi, H.1
Biddle, A.2
Gammon, L.3
Emich, H.4
Rodini, C.O.5
Gemenetzidis, E.6
-
101
-
-
84888985799
-
Side population cells as prototype of chemoresistant, tumor-initiating cells
-
Richard, V., Nair, M. G., Santhosh Kumar, T. R., & Pillai, M. R. (2013). Side population cells as prototype of chemoresistant, tumor-initiating cells. BioMed Research International. doi:10.1155/2013/517237.
-
(2013)
BioMed Research International
-
-
Richard, V.1
Nair, M.G.2
Santhosh Kumar, T.R.3
Pillai, M.R.4
-
102
-
-
62449230721
-
Identification of cancer stem cells in Ewing’s sarcoma
-
PID: 19208848
-
Suvà, M. L., Riggi, N., Stehle, J. C., Baumer, K., Tercier, S., Joseph, J. M., et al. (2009). Identification of cancer stem cells in Ewing’s sarcoma. Cancer Research, 69(5), 1776–81.
-
(2009)
Cancer Research
, vol.69
, Issue.5
, pp. 1776-1781
-
-
Suvà, M.L.1
Riggi, N.2
Stehle, J.C.3
Baumer, K.4
Tercier, S.5
Joseph, J.M.6
-
103
-
-
84855412217
-
Concise review: cancer stem cells and minimal residual disease
-
Ghiaur, G., Gerber, J., & Jones, R. J. (2012). Concise review: cancer stem cells and minimal residual disease. Stem Cells, 308(1), 89–93.
-
(2012)
Stem Cells
, vol.308
, Issue.1
, pp. 89-93
-
-
Ghiaur, G.1
Gerber, J.2
Jones, R.J.3
-
104
-
-
44749090941
-
Hyaluronan: a constitutive regulator of chemoresistance and malignancy in cancer cells
-
COI: 1:CAS:528:DC%2BD1cXntlGhtrk%3D, PID: 18534864
-
Toole, B. P., & Slomiany, M. G. (2008). Hyaluronan: a constitutive regulator of chemoresistance and malignancy in cancer cells. Seminars in Cancer Biology, 18(4), 244–50.
-
(2008)
Seminars in Cancer Biology
, vol.18
, Issue.4
, pp. 244-250
-
-
Toole, B.P.1
Slomiany, M.G.2
-
105
-
-
23044491699
-
The CD44 receptor interacts with P-glycoprotein to promote cell migration and invasion in cancer
-
PID: 16061646
-
Miletti-González, K. E., Chen, S., Muthukumaran, N., Saglimbeni, G. N., Wu, X., Yang, J., et al. (2005). The CD44 receptor interacts with P-glycoprotein to promote cell migration and invasion in cancer. Cancer Research, 65(15), 6660–7.
-
(2005)
Cancer Research
, vol.65
, Issue.15
, pp. 6660-6667
-
-
Miletti-González, K.E.1
Chen, S.2
Muthukumaran, N.3
Saglimbeni, G.N.4
Wu, X.5
Yang, J.6
-
106
-
-
20144385541
-
Regulation of MDR1 expression and drug resistance by a positive feedback loop involving hyaluronan, phosphoinositide 3-kinase, and ErbB2
-
COI: 1:CAS:528:DC%2BD2MXktlCmurw%3D, PID: 15784621
-
Misra, S., Ghatak, S., & Toole, B. P. (2005). Regulation of MDR1 expression and drug resistance by a positive feedback loop involving hyaluronan, phosphoinositide 3-kinase, and ErbB2. The Journal of Biological Chemistry, 280(21), 20310–5.
-
(2005)
The Journal of Biological Chemistry
, vol.280
, Issue.21
, pp. 20310-20315
-
-
Misra, S.1
Ghatak, S.2
Toole, B.P.3
-
107
-
-
84953388910
-
Upregulation of CD44v6 contributes to acquired chemoresistance via the modulation of autophagy in colon cancer SW480 cells
-
Lv, L., Liu, H.G., Dong, S.Y., Yang, F., Wang, Q.X., & Guo, G.L., et al. (2016). Upregulation of CD44v6 contributes to acquired chemoresistance via the modulation of autophagy in colon cancer SW480 cells. Tumour Biology. doi:10.1007/s13277-015-4755-6.
-
(2016)
Tumour Biology
-
-
Lv, L.1
Liu, H.G.2
Dong, S.Y.3
Yang, F.4
Wang, Q.X.5
Guo, G.L.6
-
108
-
-
77957234813
-
Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression
-
COI: 1:CAS:528:DC%2BC3cXht1WlsrfE, PID: 20736947
-
Hao, J., Chen, H., Madigan, M. C., Cozzi, P. J., Beretov, J., Xiao, W., et al. (2010). Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression. British Journal of Cancer, 103(7), 1008–18.
-
(2010)
British Journal of Cancer
, vol.103
, Issue.7
, pp. 1008-1018
-
-
Hao, J.1
Chen, H.2
Madigan, M.C.3
Cozzi, P.J.4
Beretov, J.5
Xiao, W.6
-
109
-
-
0032508627
-
Reversal of intrinsic and acquired forms of drug resistance by hyaluronidase treatment of solid tumors
-
COI: 1:CAS:528:DyaK1cXmvFWhtbs%3D, PID: 9839618
-
St Croix, B., Man, S., & Kerbel, R. S. (1998). Reversal of intrinsic and acquired forms of drug resistance by hyaluronidase treatment of solid tumors. Cancer Letters, 131(1), 35–44.
-
(1998)
Cancer Letters
, vol.131
, Issue.1
, pp. 35-44
-
-
St Croix, B.1
Man, S.2
Kerbel, R.S.3
-
110
-
-
84942278962
-
Selective activation of cancer stem cells by size-specific hyaluronan in head and neck cancer
-
PID: 26448762
-
Shiina, M., & Bourguignon, L. Y. (2015). Selective activation of cancer stem cells by size-specific hyaluronan in head and neck cancer. International Journal of Cell Biology. doi:10.1155/2015/989070.
-
(2015)
International Journal of Cell Biology
-
-
Shiina, M.1
Bourguignon, L.Y.2
-
111
-
-
84862909092
-
Hyaluronan synthase HAS2 promotes tumor progression in bone by stimulating the interaction of breast cancer stem-like cells with macrophages and stromal cells
-
COI: 1:CAS:528:DC%2BC38Xos1Kkug%3D%3D, PID: 22113945
-
Okuda, H., Kobayashi, A., Xia, B., Watabe, M., Pai, S. K., Hirota, S., et al. (2012). Hyaluronan synthase HAS2 promotes tumor progression in bone by stimulating the interaction of breast cancer stem-like cells with macrophages and stromal cells. Cancer Research, 72(2), 537–47.
-
(2012)
Cancer Research
, vol.72
, Issue.2
, pp. 537-547
-
-
Okuda, H.1
Kobayashi, A.2
Xia, B.3
Watabe, M.4
Pai, S.K.5
Hirota, S.6
-
112
-
-
84903515259
-
TGFβ and matrix-regulated epithelial to mesenchymal transition
-
COI: 1:CAS:528:DC%2BC2cXksVWnsLk%3D, PID: 24561266
-
Moustakas, A., & Heldin, P. (2014). TGFβ and matrix-regulated epithelial to mesenchymal transition. Biochimica et Biophysica Acta, 1840(8), 2621–34.
-
(2014)
Biochimica et Biophysica Acta
, vol.1840
, Issue.8
, pp. 2621-2634
-
-
Moustakas, A.1
Heldin, P.2
-
113
-
-
0242412978
-
Elevated hyaluronan production induces mesenchymal and transformed properties in epithelial cells
-
COI: 1:CAS:528:DC%2BD3sXosl2itrY%3D, PID: 12954618
-
Zoltan-Jones, A., Huang, L., Ghatak, S., & Toole, B. P. (2003). Elevated hyaluronan production induces mesenchymal and transformed properties in epithelial cells. The Journal of Biological Chemistry, 278(46), 45801–10.
-
(2003)
The Journal of Biological Chemistry
, vol.278
, Issue.46
, pp. 45801-45810
-
-
Zoltan-Jones, A.1
Huang, L.2
Ghatak, S.3
Toole, B.P.4
-
114
-
-
0035902816
-
Hyaluronan production increases the malignant properties of mesothelioma cells
-
COI: 1:CAS:528:DC%2BD3MXmvFKks7o%3D, PID: 11506502
-
Li, Y., & Heldin, P. (2001). Hyaluronan production increases the malignant properties of mesothelioma cells. British Journal of Cancer, 85(4), 600–7.
-
(2001)
British Journal of Cancer
, vol.85
, Issue.4
, pp. 600-607
-
-
Li, Y.1
Heldin, P.2
-
115
-
-
84884208384
-
Efficient TGFβ-induced epithelial-mesenchymal transition depends on hyaluronan synthase HAS2
-
COI: 1:CAS:528:DC%2BC38XhsFyjsb3E, PID: 23108409
-
Porsch, H., Bernert, B., Mehić, M., Theocharis, A. D., Heldin, C. H., & Heldin, P. (2013). Efficient TGFβ-induced epithelial-mesenchymal transition depends on hyaluronan synthase HAS2. Oncogene, 32(37), 4355–65.
-
(2013)
Oncogene
, vol.32
, Issue.37
, pp. 4355-4365
-
-
Porsch, H.1
Bernert, B.2
Mehić, M.3
Theocharis, A.D.4
Heldin, C.H.5
Heldin, P.6
-
116
-
-
84949982731
-
The role of CD44 in epithelial-mesenchymal transition and cancer development
-
Xu, H., Tian, Y., Yuan, X., Wu, H., Liu, Q., Pestell, R. G., & Wu, K. (2015). The role of CD44 in epithelial-mesenchymal transition and cancer development. Onco Targets and Theraphy, 8, 3783–92.
-
(2015)
Onco Targets and Theraphy
, vol.8
, pp. 3783-3792
-
-
Xu, H.1
Tian, Y.2
Yuan, X.3
Wu, H.4
Liu, Q.5
Pestell, R.G.6
Wu, K.7
-
117
-
-
84907270573
-
Excessive hyaluronan production promotes acquisition of cancer stem cell signatures through the coordinated regulation of Twist and the transforming growth factor β (TGF-β)-Snail signaling axis
-
COI: 1:CAS:528:DC%2BC2cXhsFOqtrjL, PID: 25077968
-
Chanmee, T., Ontong, P., Mochizuki, N., Kongtawelert, P., Konno, K., & Itano, N. (2014). Excessive hyaluronan production promotes acquisition of cancer stem cell signatures through the coordinated regulation of Twist and the transforming growth factor β (TGF-β)-Snail signaling axis. The Journal of Biological Chemistry, 289(38), 26038–56.
-
(2014)
The Journal of Biological Chemistry
, vol.289
, Issue.38
, pp. 26038-26056
-
-
Chanmee, T.1
Ontong, P.2
Mochizuki, N.3
Kongtawelert, P.4
Konno, K.5
Itano, N.6
-
118
-
-
84935138318
-
Perspectives of CD44 targeting therapies
-
COI: 1:CAS:528:DC%2BC2cXitVeru7%2FL, PID: 25472903
-
Orian-Rousseau, V., & Ponta, H. (2015). Perspectives of CD44 targeting therapies. Archives of Toxicology, 89(1), 3–14.
-
(2015)
Archives of Toxicology
, vol.89
, Issue.1
, pp. 3-14
-
-
Orian-Rousseau, V.1
Ponta, H.2
-
119
-
-
84918815230
-
A mesenchymal-like phenotype and expression of CD44 predict lack of apoptotic response to sorafenib in liver tumor cells
-
Fernando, J., Malfettone, A., Cepeda, E. B., Vilarrasa-Blasi, R., Bertran, E., Raimondi, G., et al. (2015). A mesenchymal-like phenotype and expression of CD44 predict lack of apoptotic response to sorafenib in liver tumor cells. International Journal of Cancer, 136(4), 161–72.
-
(2015)
International Journal of Cancer
, vol.136
, Issue.4
, pp. 161-172
-
-
Fernando, J.1
Malfettone, A.2
Cepeda, E.B.3
Vilarrasa-Blasi, R.4
Bertran, E.5
Raimondi, G.6
-
120
-
-
84884366170
-
Silibinin inhibits β-catenin/ZEB1 signaling and suppresses bladder cancer metastasis via dual-blocking epithelial-mesenchymal transition and stemness
-
COI: 1:CAS:528:DC%2BC3sXhs1OrurzI, PID: 24012496
-
Wu, K., Ning, Z., Zeng, J., Fan, J., Zhou, J., Zhang, T., et al. (2013). Silibinin inhibits β-catenin/ZEB1 signaling and suppresses bladder cancer metastasis via dual-blocking epithelial-mesenchymal transition and stemness. Cellular Signalling, 25(12), 2625–33.
-
(2013)
Cellular Signalling
, vol.25
, Issue.12
, pp. 2625-2633
-
-
Wu, K.1
Ning, Z.2
Zeng, J.3
Fan, J.4
Zhou, J.5
Zhang, T.6
-
121
-
-
0028216487
-
Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development
-
COI: 1:CAS:528:DyaK2cXktlahsLc%3D, PID: 7516417
-
Bartolazzi, A., Peach, R., Aruffo, A., & Stamenkovic, I. (1994). Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. Journal of Experimental Medicine, 180(1), 53–66.
-
(1994)
Journal of Experimental Medicine
, vol.180
, Issue.1
, pp. 53-66
-
-
Bartolazzi, A.1
Peach, R.2
Aruffo, A.3
Stamenkovic, I.4
-
122
-
-
0031453690
-
Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function
-
COI: 1:CAS:528:DyaK2sXotVGhs7Y%3D, PID: 9396767
-
Yu, Q., Toole, B. P., & Stamenkovic, I. (1997). Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function. Journal of Experimental Medicine, 186(12), 1985–96.
-
(1997)
Journal of Experimental Medicine
, vol.186
, Issue.12
, pp. 1985-1996
-
-
Yu, Q.1
Toole, B.P.2
Stamenkovic, I.3
-
123
-
-
34249748770
-
Down-regulation of CD44 contributes to the differentiation of HL-60 cells induced by ATRA or HMBA
-
COI: 1:CAS:528:DC%2BD2sXkvVWqsrc%3D
-
Liu, J., Bi, G., Wen, P., Yang, W., Ren, X., Tang, T., et al. (2007). Down-regulation of CD44 contributes to the differentiation of HL-60 cells induced by ATRA or HMBA. Cellular & Molecular Immunology, 4(1), 59–63.
-
(2007)
Cellular & Molecular Immunology
, vol.4
, Issue.1
, pp. 59-63
-
-
Liu, J.1
Bi, G.2
Wen, P.3
Yang, W.4
Ren, X.5
Tang, T.6
-
124
-
-
0037063999
-
Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway
-
COI: 1:CAS:528:DC%2BD38Xns1CgtbY%3D, PID: 12145277
-
Ghatak, S., Misra, S., & Toole, B. P. (2002). Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway. Journal of Biological Chemistry, 277(41), 38013–20.
-
(2002)
Journal of Biological Chemistry
, vol.277
, Issue.41
, pp. 38013-38020
-
-
Ghatak, S.1
Misra, S.2
Toole, B.P.3
-
125
-
-
84973622233
-
Hyaluronan/Hyaladherins - a promising axis for targeted drug delivery in cancer
-
Nikitovic, D., Kouvidi, K., Kavasi, R.M., Berdiaki, A., & Tzanakakis, G.N. (2016). Hyaluronan/Hyaladherins - a promising axis for targeted drug delivery in cancer. Current Drug Delivery, 13, 1–12.
-
(2016)
Current Drug Delivery
, vol.13
, pp. 1-12
-
-
Nikitovic, D.1
Kouvidi, K.2
Kavasi, R.M.3
Berdiaki, A.4
Tzanakakis, G.N.5
-
126
-
-
84949624567
-
pH sensitive polymeric complex of cisplatin with hyaluronic acid exhibits tumor-targeted delivery and improved in vivo antitumor effect
-
COI: 1:CAS:528:DC%2BC2MXhvVehur3I, PID: 26529576
-
Fan, X., Zhao, X., Qu, X., & Fang, J. (2015). pH sensitive polymeric complex of cisplatin with hyaluronic acid exhibits tumor-targeted delivery and improved in vivo antitumor effect. International Journal of Pharmaceutics, 496(2), 644–53.
-
(2015)
International Journal of Pharmaceutics
, vol.496
, Issue.2
, pp. 644-653
-
-
Fan, X.1
Zhao, X.2
Qu, X.3
Fang, J.4
-
127
-
-
0033200301
-
Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate
-
COI: 1:CAS:528:DyaK1MXksF2ltLs%3D, PID: 10502340
-
Luo, Y., & Prestwich, G. D. (1999). Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate. Bioconjugate Chemistry, 10(5), 755–63.
-
(1999)
Bioconjugate Chemistry
, vol.10
, Issue.5
, pp. 755-763
-
-
Luo, Y.1
Prestwich, G.D.2
-
128
-
-
84863866947
-
Hyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancer
-
Choi, K. Y., Saravanakumar, G., Park, J. H., & Park, K. (2012). Hyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancer. Colloids and Surfaces. B, Biointerfaces, 1(99), 82–94.
-
(2012)
Colloids and Surfaces. B, Biointerfaces
, vol.1
, Issue.99
, pp. 82-94
-
-
Choi, K.Y.1
Saravanakumar, G.2
Park, J.H.3
Park, K.4
-
129
-
-
84862539273
-
CD44: a validated target for improved delivery of cancer therapeutics
-
COI: 1:CAS:528:DC%2BC38Xos1ajtL0%3D, PID: 22621669
-
Ghosh, S. C., Neslihan Alpay, S., & Klostergaard, J. (2012). CD44: a validated target for improved delivery of cancer therapeutics. Expert Opinion on Therapeutic Targets, 16(7), 635–50.
-
(2012)
Expert Opinion on Therapeutic Targets
, vol.16
, Issue.7
, pp. 635-650
-
-
Ghosh, S.C.1
Neslihan Alpay, S.2
Klostergaard, J.3
-
130
-
-
79955063673
-
Hyaluronan-CD44 interactions as potential targets for cancer therapy
-
COI: 1:CAS:528:DC%2BC3MXls1Oit7w%3D, PID: 21362138
-
Misra, S., Heldin, P., Hascall, V. C., Karamanos, N. K., Skandalis, S. S., Markwald, R. R., & Ghatak, S. (2011). Hyaluronan-CD44 interactions as potential targets for cancer therapy. FEBS Journal, 278(9), 1429–43.
-
(2011)
FEBS Journal
, vol.278
, Issue.9
, pp. 1429-1443
-
-
Misra, S.1
Heldin, P.2
Hascall, V.C.3
Karamanos, N.K.4
Skandalis, S.S.5
Markwald, R.R.6
Ghatak, S.7
-
131
-
-
84978886872
-
Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo
-
COI: 1:CAS:528:DC%2BC28Xhs1CqtLg%3D, PID: 26851390
-
Zhong, Y., Goltsche, K., Cheng, L., Xie, F., Meng, F., Deng, C., et al. (2016). Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo. Biomaterials, 84, 250–61.
-
(2016)
Biomaterials
, vol.84
, pp. 250-261
-
-
Zhong, Y.1
Goltsche, K.2
Cheng, L.3
Xie, F.4
Meng, F.5
Deng, C.6
-
132
-
-
84961301672
-
Hyaluronic acid-coated PEI-PLGA nanoparticles mediated co-delivery of doxorubicin and miR-542-3p for triple negative breast cancer therapy
-
COI: 1:CAS:528:DC%2BC28XhtlKgug%3D%3D, PID: 26711968
-
Wang, S., Zhang, J., Wang, Y., & Chen, M. (2016). Hyaluronic acid-coated PEI-PLGA nanoparticles mediated co-delivery of doxorubicin and miR-542-3p for triple negative breast cancer therapy. Nanomedicine, 12(2), 411–20.
-
(2016)
Nanomedicine
, vol.12
, Issue.2
, pp. 411-420
-
-
Wang, S.1
Zhang, J.2
Wang, Y.3
Chen, M.4
-
133
-
-
84954509352
-
Hyaluronic acid modified pH-sensitive liposomes for targeted intracellular delivery of doxorubicin
-
Paliwal, S.R., Paliwal, R., Agrawal, G.P., & Vyas, S.P. (2016). Hyaluronic acid modified pH-sensitive liposomes for targeted intracellular delivery of doxorubicin. Journal of Liposome Research:1–12.
-
(2016)
Journal of Liposome Research
, pp. 1-12
-
-
Paliwal, S.R.1
Paliwal, R.2
Agrawal, G.P.3
Vyas, S.P.4
|